Biosyent Investor Relations Material
Latest events
Q1 2025
Biosyent
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Biosyent Inc
Access all reports
BioSyent Inc., a specialty pharmaceutical company, sources, acquires or in-licenses, develops, and sells pharmaceutical and other healthcare products in Canada. It focuses on the acquisition of oncology drugs, medical devices and other healthcare products. BioSyent Inc. is based in Mississauga, Canada.
Key slides for Biosyent Inc
Q4 2024
Biosyent Inc
Q4 2024
Biosyent Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
RX
Country
🇨🇦 Canada